REGENERON PHARMACEUTICALS INC revenue breakdown overview

REGENERON PHARMACEUTICALS INC revenue for the last year amounted to 12.90 B CHF, the most of which — 12.90 B CHF — came from its highest performing source at the moment, Medicines, the year earlier bringing 11.04 B CHF. The greatest contribution to the revenue figure was made by United States — last year it brought REGENERON PHARMACEUTICALS INC 6.54 B CHF, and the year before that — 5.69 B CHF.